Ionis Pharmaceuticals Inc
NASDAQ:IONS 4:00:00 PM EDT
Products
Ionis Receives FDA Fast Track Designation For Olezarsen
Published: 01/31/2023 14:26 GMT
Ionis Pharmaceuticals Inc (IONS) - Ionis Receives FDA Fast Track Designation for Olezarsen in Patients With Familial Chylomicronemia Syndrome.
Ionis Pharmaceuticals Inc - If Approved, Olezarsen Would Be First Approved Treatment for Fcs in U.S.ionis Pharmaceuticals Inc - Company Plans to Share Data From Balance Study in Second Half of 2023.
Ionis Pharmaceuticals Inc - If Approved, Olezarsen Would Be First Approved Treatment for Fcs in U.S.ionis Pharmaceuticals Inc - Company Plans to Share Data From Balance Study in Second Half of 2023.